| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease. | Mol Neurodegener | 2010 | 1.18 |
| 2 | Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin. | J Biol Chem | 2006 | 0.95 |
| 3 | A quantitative homogeneous assay for fragile X mental retardation 1 protein. | J Neurodev Disord | 2013 | 0.85 |
| 4 | Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors. | Mol Neurodegener | 2010 | 0.85 |
| 5 | Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice. | Neurobiol Aging | 2013 | 0.79 |
| 6 | Transcriptional activation of the utrophin promoter B by a constitutively active Ets-transcription factor. | Neuromuscul Disord | 2003 | 0.78 |